NOUVEAU COMPOSE OU SON SEL PHARMACEUTIQUEMENT ACCEPTE

• 收藏
• 分享

专利权人:

RIKEN;JAPANESE FOUNDATION FOR CANCER RESEARCH

发明人:

YOSHIDA, MINORU,SEIMIYA, HIROYUKI,OKUE, MASAYUKI,YASHIRODA, YOKO,SHIRAI, FUMIYUKI,TSUMURA, TAKESHI,KANO, YUKO,WASHIZUKA, KENICHI,YOSHIMOTO, NOBUKO,KOUDA, YASUKO,FUKAMI, TAKEHIRO,CHIKADA, TSUBASA,WATAN

申请号：

CA3029305

公开号：

CA3029305A1

申请日:

2017.06.30

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

2- (Piperidin-1-yl) pyrimidin-4 (3H) -ones characterized by having a 1,8-diazaspiro [4.5] deca-3-ene, 1-oxa-8-azaspiro [4.5] deca-3-ene, 2,8-diazaspiro [4.5] deca-3-ene, 2-oxa-8-azaspiro [4.5] deca-3-ene, 2,9-diazaspiro [5.5] undeca-3-ene, 1-oxa-9-azaspiro [5.5] undeca-3-ene, 1,9-diazaspiro [5.5] undeca-4-ene, or 3,9-diazaspiro [5.5] undeca-1-ene structure represented by general formula (1), or a pharmaceutically acceptable salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/